Inhaled Dry Powder Antibiotics in Patients with Non-Cystic Fibrosis Bronchiectasis: Efficacy and Safety in a Real-Life Study.
Miguel Ángel Martínez-GarcíaFernando Santamaría-MartosEsther BarreiroSelene CuencaAngela CerveraAlicia Padilla-GaloDavid la Rosa-CarrilloAnnie NavarroRosa GironFrancisco CarboneroMaria Castro OteroFrancisco CasasPublished in: Journal of clinical medicine (2020)
Our study suggests that DPIA are clinically efficacious and safe for treating bronchiectasis patients. Cough was shown to be the most common side-effect and reason for withdrawal of the treatment.